Redmile Group’s Repligen RGEN Stock Holding History

Redmile Group’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,020	Closed	-$317K	–	86
2018 Q4	$317K	Sell	6,020 -13,980	-70%	-$820K	0.01%	68
2018 Q3	$1.11M	Buy	+20,000	New	+$1.03M	0.03%	70

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Redmile Group's RGEN Position: Q1 2019 in Review

Redmile Group sold out of Repligen (RGEN) in Q1 2019, closing a stake of 6,020 shares — an estimated $317K sold.

Redmile Group first reported a position in RGEN in Q3 2018 and held it in 2 quarters. The position peaked at $1.11M in Q3 2018. 252 funds tracked by Wall St. Rank hold RGEN as of Q1 2019.

Redmile Group reported no remaining Repligen position as of Q1 2019 after selling out during the quarter.
Redmile Group sold 6,020 Repligen shares in Q1 2019, an estimated $317K.
Redmile Group first reported a position in Repligen in Q3 2018 and held it in 2 quarters.
Redmile Group's Repligen position peaked at $1.11M in Q3 2018.
252 funds tracked by Wall St. Rank held Repligen as of Q1 2019.

Based on Redmile Group's 13F filing for Q1 2019, filed 15 May 2019.